Physician profile
Kosana Lee
NPI 1508113606
$875.83
in general payments reported to CMS, 2019-2025
9 companies · $140 in 2025
The $140 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.93 · 2022: $19.93 · 2023: $133 · 2024: $520 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $792.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $430.50 | 2023-2024 | Eterna, Proclaim |
| Boston Scientific Corporation | $187.33 | 2024 | |
| Merck Sharp & Dohme LLC | $82.37 | 2024-2025 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $62.93 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $38.55 | 2025 | Lifevest |
| Pfizer INC. | $19.93 | 2022 | |
| Paratek Pharmaceuticals, INC. | $18.88 | 2025 | Nuzyra |
| Janssen Pharmaceuticals, INC | $17.86 | 2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.48 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kosana Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.